NASDAQ: HIVEHive Digital Technologies Ltd Stock
$1.68-0.13 (-7.18%)
Updated Mar 26, 2025
HIVE Price
$1.68
Fair Value Price
N/A
Market Cap
$235.54M
52 Week Low
$1.61
52 Week High
$5.54
P/E
-42x
P/B
0.54x
P/S
3.03x
PEG
N/A
Dividend Yield
N/A
Revenue
$121.00M
Earnings
-$6.59M
Gross Margin
74.8%
Operating Margin
-0.91%
Profit Margin
-5.4%
Debt to Equity
0.1
Operating Cash Flow
-$43M
Beta
2.94
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
HIVE Overview
HIVE Blockchain Technologies Ltd. is a cryptocurrency (Ethereum, Ethereum Classic, Bitcoin) mining company in Canada, Sweden, and Iceland. Known as Leeta Gold Corp. until 2017, HIVE Blockchain Technologies was incorporated in 1987 and is headquartered in Vancouver, British Columbia, Canada.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine HIVE's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
D
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Capital Market
Industry Rating
D
HIVE
Ranked#40 of 53
Ranked#40 of 53
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $38.54 | A | |
| $9.71 | A | |
| $6.56 | B |
Be the first to know about important HIVE news, forecast changes, insider trades & much more!
HIVE News
Overview
Due Diligence Score
–
Industry Average (32)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how HIVE scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
HIVE is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
HIVE is good value based on its book value relative to its share price (0.54x), compared to the US Capital Markets industry average (2.18x)
P/B vs Industry Valuation
HIVE is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more HIVE due diligence checks available for Premium users.
Valuation
HIVE price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-42x
Industry
20.5x
Market
31.65x
HIVE price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.54x
Industry
2.18x
HIVE is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
HIVE's financial health
Profit margin
Revenue
$29.2M
Net Income
$1.3M
Profit Margin
4.3%
HIVE's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
HIVE's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$478.6M
Liabilities
$44.2M
Debt to equity
0.1
HIVE's short-term assets ($310.26M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HIVE's short-term assets ($310.26M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HIVE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$18.6M
Investing
-$62.5M
Financing
$83.8M
HIVE's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
HIVE vs Capital Market Stocks
Hive Digital Technologies Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.